You must have Credits on your Balance to download this sample
Pages 7 (1757 words)
Country/product Brief Abstract This study will focus on globalization strategy of an Indian pharmaceutical company. The purpose of the report is to analyze the market entry opportunity for an Indian pharmaceutical company in USA. Organization selected for the study is Lupin Ltd, which is an Indian MNC catering to more than 70 countries across the globe.
Table of Contents 2.1 Political Factor 5 2.2 Economic Factor 6 2.3 Social Factor 6 2.4 Technological Factor 7 2.5 Environmental Factor 7 2.6 Legal Factor 7 4.1 Opportunities 9 4.2 Barriers 9 Global pharmaceutical market is valued at € 484,151million but more than 47% of the market share is dominated by USA alone. US pharmaceutical industry has discovered almost 370 different drugs in last decade. 50% of drugs are in the area of heart disease or hypertension, Alzheimer’s disease, arthritis, Parkinson’s, and Cancer. Some of the well known pharmaceutical companies of USA are Amgen, Pfizer, Marc, and Bristol-Myers Squibb among others (Economy Watch, 2010). The pharmaceutical market is highly competitive as a number of established pharmaceutical companies operate in USA. In the context of the study Lupin Limited, an Indian pharmaceutical giant has been chosen as the organization to conduct the study. The next half of the report will present a brief background of the firm. 1.1 Background Lupin Limited is one of the Ivy League pharmaceutical companies of India. The company is presently headquartered in Mumbai, Maharashtra, India. It was founded in the year 1968 by Desh Bandhu Gupta. The company is known for providing best healthcare solution across the world. ...
Not exactly what you need?